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Background-—Atherosclerosis progression during aging culminates in the development of vulnerable plaques, which may increase
the risk of cardiovascular events. Increased generation and/or decreased scavenging of reactive oxygen species in the vascular
wall are major contributors to atherogenesis. We previously showed that superoxide dismutase 2 deficiency increased vascular
oxidative stress and reduced aortic compliance in aged wild-type mice and that young Apoe//Sod2+/ had increased
mitochondrial DNA damage and atherosclerosis versus young Apoe/ mice. Here we investigated the effects of superoxide
dismutase 2 deficiency on atherosclerosis progression and plaque morphology in middle-aged Apoe/ mice.
Methods and Results-—Compared with Apoe/, middle-aged Apoe//Sod2+/ mice had increased vascular wall reactive
oxygen species (P<0.05) and higher atherosclerotic lesion area (P<0.001). The atherosclerotic plaques in middle-aged Apoe//
Sod2+/ mice had an increased necrotic core with higher inflammatory cell infiltration, a thinned fibrous cap with depleted smooth
muscle content, and intraplaque hemorrhage. In addition, the plaque shoulder area had higher levels of calpain-2, caspase-3, and
matrix metalloproteinase-2 in intimal smooth muscle cells and depleted fibrous cap collagen. Targeting mitochondrial reactive
oxygen species with MitoTEMPO attenuated features of atherosclerotic plaque vulnerability in middle-aged Apoe//Sod2+/
mice by lowering expression of calpain-2, caspase-3, and matrix metalloproteinase-2 and decreasing smooth muscle cell apoptosis
and matrix degradation.
Conclusions-—Enhanced mitochondrial oxidative stress under hyperlipidemic conditions in aging induces plaque instability, in part
by increasing smooth muscle cell apoptosis, necrotic core expansion, and matrix degradation. Targeting mitochondrial reactive
oxygen species or its effectors may be a viable therapeutic strategy to prevent aging-associated and oxidative stress–related
atherosclerosis complications. ( J Am Heart Assoc. 2017;6:e006775. DOI: 10.1161/JAHA.117.006775.)
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C ardiovascular diseases, including atherosclerosis and itssequelae, are leading causes of death in the Western
world. Together, ischemic heart disease and stroke were
responsible for over 10 million deaths globally in 20131 and
for 1 in 3 deaths in the United States.2 Atherosclerotic plaque
temporal changes are characterized by progression from
pathological intimal thickening to fibroatheroma to thin-cap
fibroatheroma and, ultimately, to plaque rupture and throm-
bus formation.3 The culprit plaque, often described as
unstable or vulnerable plaque, is characterized by a large
necrotic core and a thin fibrous cap infiltrated with
macrophages and lymphocytes and with the absence of or a
few smooth muscle cells (SMC).4,5 The pathophysiology of
vulnerable atherosclerotic plaque has been extensively stud-
ied; however, the exact molecular mechanisms of plaque
progression and the triggers of plaque rupture remain largely
unknown.
Aging is one of the major nonmodifiable risk factors for
atherosclerosis and related vascular complications. The
prevalence of coronary heart disease is 10-fold greater in
the 40- to 59-year age group than in the 20- to 39-year age
group, increasing linearly in the older population.2 Similarly,
the prevalence of cardiovascular disease is 4-fold greater in
the 40- to 59-year group versus the 20- to 39-year age group,
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increasing rapidly in the older population, albeit in a nonlinear
fashion. Cardiovascular aging is associated with chronic
vascular inflammation and dysfunction, extensive extracellular
matrix remodeling, and fibrotic changes.6,7 At the cellular
level, aging results in enhanced oxidative stress and macro-
molecular damage, increased cell proliferation, senescence,
and apoptosis. Further, increased levels of reactive oxygen
species (ROS) in the vascular wall were implicated as
causative during all clinical stages of atherosclerosis.8
Consistent with this, aging was associated with increased
cellular and mitochondrial ROS (mtROS) in the vascular cells
and augmented atherosclerotic lesions with enhanced
macrophage infiltration in hypercholesterolemic mice.9 Fur-
ther, aging-associated mitochondrial oxidative stress (mtOS)
resulted in mitochondrial DNA (mtDNA) damage, mitochon-
drial and vascular dysfunction, and atherosclerosis.10,11 The
cellular redox balance in aging vasculature shifts toward
decreased levels of antioxidant enzymes, including mitochon-
drial superoxide dismutase 2 (SOD2).12 We previously showed
that SOD2 deficiency in aging mice results in vascular SMC
apoptosis and matrix remodeling, leading to increased
vascular and cardiac dysfunction.13 Additionally, middle-aged
Apoe/ mice fed a Western diet had increased mtROS
levels, and treatment with MitoTEMPO, a mitochondrial
antioxidant, decreased atherosclerosis and preserved vascu-
lar and cardiac function.9
The current study investigated whether SOD2 deficiency in
oxidative stress- and atherosclerosis-prone middle-aged
Apoe/ mice exacerbates atherosclerotic plaque burden
and induces plaque instability, using young (4-month-old) and
middle-aged (16-month old) Apoe/ and Apoe//Sod2+/
mice fed a high-fat diet. We found that SOD2 deficiency in
middle-aged Apoe/ mice further increased mtROS levels,
nuclear and mtDNA damage, mitochondrial dysfunction,
activation of calcium-sensitive proteases, SMC apoptosis,
and progressive expansion of atherosclerotic lesions with
features of vulnerable plaque. In addition, pharmacological
targeting of mtROS in middle-aged Apoe/ and Apoe//
Sod2+/ mice attenuated atherosclerosis and improved
plaque stability, implicating mitochondrial dysfunction in
aging-associated atherosclerotic complications under hyper-
lipidemic conditions.
Methods
Animals
All procedures were performed in compliance with protocols
approved by the University of Michigan Institutional Animal
Care and Use Committee in accordance with NIH guidelines.
All mice were purchased from Jackson Laboratory (Bar Harbor,
ME). Male wild-type, Sod2+/ (B6.129S7-Sod2tm1Leb/J),
Apoe/ (B6.129P2-Apoetm1Unc/J), and Apoe//Sod2+/
mice were bred on the C57BL/6J background. Experimental
mice were generated from breeding heterozygous mice, and
genotypes were confirmed by polymerase chain reaction.
Mice were housed in specific pathogen-free rooms in
ventilated cages at 22°C with 12-hour light/dark cycles and
free access to food and water. Animals (n=16 per group) were
fed standard rodent chow for 1 (young) or 13 months (middle-
aged) and then switched to the Western diet (Harlan Teklad
TD.88137; Envigo, Madison, WI) for 3 months.
Mice were treated with MitoTEMPO (Sigma-Aldrich, St.
Louis, MO) at 1500 lg/kg per day for 12 weeks as described
previously.9 Briefly, at 13 months of age mice were randomly
assigned to a MitoTEMPO or a vehicle treatment group
(n=12). Microosmotic pumps (ALZET 1004; Durect, Cupertino,
CA) were implanted subcutaneously under 2% inhaled isoflu-
rane/O2 anesthesia. The pumps were replaced every
4 weeks. Mice were fed the Western diet for the duration of
the experiment.
Vascular SMC Isolation, Culture, and siRNA
Transfection
The SMC were isolated from aortas of 4- and 16-month old
wild-type and Sod2+/ mice as described before.9 Aortas
from 3 to 4 animals were pooled together as 1 isolate, and 2
to 3 different isolates were used in 3 to 4 independent
experiments. Cells were grown in DMEM supplemented with
10% fetal bovine serum and an antibiotic-antimycotic in a 5%
Clinical Perspective
What Is New?
• Vascular mitochondrial oxidative stress increases with aging
under hyperlipidemic conditions, resulting in enhanced
atherosclerotic plaque inflammation, necrotic core and
fibrous cap remodeling, and susceptibility to rupture.
• Selective targeting of mitochondrial reactive oxygen species
with a superoxide dismutase mimetic attenuated features of
atherosclerotic plaque instability in aging hypercholes-
terolemic mice.
What Are the Clinical Implications?
• Screening and monitoring of elderly coronary artery disease
patients for mitochondrial oxidative stress markers such as
mitochondrial DNA damage may help identify individuals
with vulnerable plaques and increased risk of adverse
cardiovascular events.
• Using mitochondria-targeted antioxidants as adjunct ther-
apy to traditional coronary artery disease treatments may
prevent atherosclerotic plaque destabilization and reduce
atherosclerosis complications.
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CO2 incubator at 37°C. Cells were used between passages 3
and 10.
Mouse Capn2 ON-TARGET plus SMARTpool siRNA (L-
043027-00) and nontargeting siRNA control (D-001810-01)
were purchased from Dharmacon (GE Healthcare, Pittsburgh,
PA). Cells were transfected using p5RHH peptide-siRNA
nanocomplexes as described before.14 Briefly, nanocom-
plexes were prepared by mixing p5RHH peptide and siRNA
oligo at 1:200 in Opti-MEM medium and incubating for
40 minutes at 37°C. Vascular SMC (VSMC) were grown in 6-
well plates to 70% confluence, quiesced overnight in DMEM,
incubated with nanocomplexes for 4 hours at 37°C, and then
treated with tumor necrosis factor a plus interferon c
(TNFa+IFNc) or vehicle for 16 hours. Efficiency of siRNA
knockdown was confirmed by Western blot analysis.
Histology and Immunostaining
Mice were euthanized with inhaled isoflurane and perfused
with phosphate-buffered saline through a cardiac puncture.
Aortas were dissected, opened longitudinally, pinned on black
wax, stained with oil red O and 0.1% toluidine blue, and
imaged. Alternatively, aortas were fresh frozen in OCT
compound (Sakura Finetek, Torrance, CA), and transverse
serial sections were cut at 10-lm thickness every 100 lm
through aortic arch and descending thoracic aorta. Frozen
tissue sections were stained with oil red O, Verhoeff
picrosirius red, or hematoxylin and eosin, imaged, and
analyzed with NIH ImageJ 1.49 (Bethesda, MD).
Immunohistochemistry and immunofluorescence were per-
formed as described previously.9 Consecutive adjacent sec-
tions from ascending aorta and aortic arch were stained for
various markers, and representative images from several mice
(n=6-8) were selected. The antibodies used were against
CD11b (Abnova, Walnut, CA), a-smooth muscle actin, CD3c
(Abcam, Cambridge, MA), a-smooth muscle actin FITC-
conjugated (Sigma-Aldrich, St. Louis, MO), calpain-2 large
subunit, cleaved caspase-3 (Cell Signaling Technology, Dan-
vers, MA), matrix metalloproteinase 2 (MMP2), ATP5G2,
VCAM1, CD68 Cy3-conjugated (Bioss, Woburn, MA), 8-
hydroxyguanosine (8-OHdG), erythroid cell antibody
(TER119) and Alexa Fluor 594 goat anti-rabbit IgG, Alexa
Fluor 488 goat anti-rabbit IgG, or Alexa Fluor 568 rabbit anti-
goat IgG (Thermo Scientific, Waltham, MA). Sections were
mounted with Vectastain mounting medium for fluorescence
with 40,6-diamidino-2-phenylindole (DAPI) (Vector Laborato-
ries, Burlingame, CA). Fluorescence or bright-field images
were acquired with a Nikon Microphot-FX microscope at the
same exposure, gain, and offset. Fluorescent images for each
color channel were merged using Adobe Photoshop CC.
Fluorescence intensity was determined by integrated density
(mean gray value per area) measured with NIH ImageJ in the
defined region of interest (ROI) and adjusted to the number of
cell nuclei within the ROI. In the images stained for calpain-2
and cleaved caspase-3 ROI included the fibrocellular cap at
the plaque shoulder region and adjacent media. In the images
stained for MMP2 ROI included fibrous cap, neointima, and
adjacent media at the plaque shoulder region.
In the images of the aortic section stained for 8-OHdG and
counterstained with DAPI, nuclei positive for 8-OHdG were
pseudocolored green and counted as a fraction of total nuclei
number per section. In the images of the aortic sections
costained for 8-OHdG, ATP5G2, and DAPI, the cells with
nonnuclear 8-OHdG and mitochondrial colocalization were
counted as a fraction of total cell number per section.15
Western Blot Analysis
Western blot analysis was performed as described.9 Primary
antibodies used were against calpain-1 (Thermo Scientific),
calpain-2 large subunit, cleaved caspase-3 (Asp175), MMP2,
phospho-H2AX (Cell Signaling Technology), and b-actin
(Sigma-Aldrich). With use of appropriate secondary horse-
radish peroxidase–conjugated antibody, protein bands were
visualized with chemiluminescent reagent on x-ray film.
Densitometric quantification was performed using NIH ImageJ
1.49.
ROS Detection
Aortic wall ROS were detected with DHE and MitoSOX Red
fluorescence as described previously.9 Fluorescence images
were taken using a Nikon Microphot-FX microscope with
510 nm excitation/580 nm emission filters. Grayscale
images were analyzed with NIH ImageJ 1.49 software to
determine mean gray value per area of the plaque and
adjacent media (integrated density).
The cellular superoxide levels were determined with HPLC
detection of 2-hydroxyethidium as described before.9,16
Briefly, after treatments VSMC were incubated with
50 lmol/L of DHE (Thermo Scientific), harvested in acetoni-
trile, and supernatants dried using Savant ISS 100 (Thermo
Scientific). Samples were dissolved in PBS and analyzed with
an Agilent 1100 HPLC system equipped with a Partisil 5 lm
ODS3 25094.6 mm column (Phenomenex, Torrance, CA).
Quantification was performed using the 2-hydroxyethidium
standard (Noxygen Science Transfer & Diagnostics GmbH,
Elzach, Germany).
TUNEL Assay
Transverse aortic sections were terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) stained using an
In Situ Cell Death Detection Kit (Roche, Indianapolis, IN)
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following the manufacturer’s protocol. Briefly, sections were
fixed in 4% paraformaldehyde, permeabilized in 0.1% Triton X-
100, and incubated with a mixture of terminal deoxynu-
cleotidyl transferase and labeled nucleotides. Sections were
mounted with Vectastain mounting medium for fluorescence
with DAPI (Vector Laroratories, Burlingame, CA). Fluorescence
images were acquired with a Nikon Microphot-FX microscope
and analyzed using NIH ImageJ 1.49 software. In the analyzed
images TUNEL-positive nuclei were pseudocolored green and
counted as a fraction of total number of nuclei within the
plaque.
In Situ Zymography
The MMP activity in the aortic wall was determined as
described previously.17 Briefly, fresh frozen aortic sections
were incubated with 20 lg/mL of DQ gelatin conjugated to
fluorescein (Thermo Scientific) for 30 minutes at 37°C. The
enzymatic activity of metalloproteinase in situ results in
accumulation of highly fluorescent peptides. Fluorescent
images were acquired with a Nikon Microphot-FX microscope
using 495 nm excitation/515 nm emission filters. Fluores-
cence intensity was determined using NIH ImageJ by
measuring integrated density normalized to the number of
cell nuclei within the defined ROI that included fibrous cap,
neointima and adjacent media at the plaque shoulder region.
Mitochondrial Protein Carbonyl Content and
Mitochondrial Function
Mitochondria were isolated from VSMC of 4- and 16-month-
old wild-type and Sod2+/ mice using the Mitochondria
Isolation Kit for Cultured Cells (Thermo Scientific) and protein
carbonyl concentration was measured using the Protein
Carbonyl Assay Kit (Cayman Chemical Company, Ann Arbor,
MI) according to the manufacturer’s protocol.
Mitochondrial complex I activity was determined by
measuring the reduction of NADH-sensitive Epsilon dye at
450 nm using Complex I Enzyme Activity Microplate Assay
Kit (Abcam) following the manufacturer’s protocol. Mitochon-
drial complex III activity was determined in isolated mito-
chondria by measuring the reduction of cytochrome C at
550 nm with antimycin A-specific activity subtracted from
the total activity to calculate complex III-specific activity, as
described in.9,18
Plasma Sample Collection, Clinical Biochemistry
Tests and Free 8-Isoprostane Levels
Plasma samples were collected from anesthetized mice
through cardiac puncture as described previously.19 Plasma
lipid levels were measured using the AMS Lyasis 330 Clinical
Chemistry System (AMS Diagnostics, Weston, FL). Plasma
ALT, creatinine, and BUN were measured on an Automated
Chemical Analyzer VT350 (Johnson & Johnson, New Bruns-
wick, NJ). Plasma levels of free 8-isoprostane were deter-
mined with the EIA kit (Cayman Chemical) according to the
manufacturer’s protocol.
Statistical Analysis
All analyses were performed using JMP Pro 11.0.0 (SAS
Institute, Cary, NC) or Prism 7 (GraphPad Software, La Jolla,
CA). All data were tested for normality using the Shapiro–Wilk
test. The data were transformed using square root, logarithm
or a reciprocal transformation until the goodness-of-fit test
was no longer reaching significance. Transformed data were
analyzed by one-way ANOVA following multiple comparisons
with correction using the Newman–Keuls test or repeated
measures ANOVA, without assuming sphericity, and with
Greenhouse–Geisser correction when multiple measurements
were made in the same animals. The untransformed data were
reported in the results. Data that did not pass the normality
test were analyzed by nonparametric test with correction for
multiple comparisons using Dunn’s test. Two-way ANOVA was
used to test for the effect of interaction between genotype
and age on atherosclerotic plaque parameters. Differences
were considered significant at P<0.05.
Results
Middle-Aged Apoe/ Mice With SOD2
Deficiency Develop Extensive, Advanced
Atherosclerotic Lesions and Show Enhanced
Vascular and mtROS Levels and DNA Damage
To test the role of impaired mitochondrial antioxidant defense
on atherogenesis in aging, we examined the atherosclerotic
plaque burden in young and middle-aged Apoe/ and
Apoe//Sod2+/ mice that were fed a Western diet.
Experimental reduction in SOD2 protein levels increased
atherosclerosis under hyperlipidemic conditions in both young
and middle-aged Apoe/ mice. Aortic atherosclerotic lesion
size increased by 60% in young Apoe//Sod2+/ compared
to young Apoe/ mice, as previously reported by us11 and by
54% in middle-aged Apoe//Sod2+/ compared to middle-
aged Apoe/ mice (Figure 1A). Aging significantly increased
the atherosclerotic burden as middle-aged Apoe/ had a
250% increase in aortic atherosclerotic lesion size compared
to young Apoe/ mice, similar to our earlier findings.9
Likewise, lifelong deficiency in SOD2 protein levels exacer-
bated aortic atherosclerosis as lesion size increased by 240%
in middle-aged compared to young Apoe//Sod2+/ mice
(Figure 1A). Moreover, middle-aged Apoe//Sod2+/ mice
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had the highest aortic atherosclerotic plaque burden, 50% of
total aortic area. In addition, 2-way ANOVA demonstrated a
significant interaction between the effects of aging and SOD2
deficiency on atherosclerotic lesion size (P=0.0102).
To assess the interactive effects of aging, SOD2 deficiency,
and hypercholesterolemia on overall vascular ROS levels, we
determined aortic wall dihydroethidium fluorescence in young
and middle-aged Apoe/ and Apoe//Sod2+/ mice fed a
Western diet. Vascular ROS levels increased by 88% in middle-
aged compared to young Apoe/ mice and by 54% in middle-
aged compared to young Apoe//Sod2+/ mice (Figure 1B).
SOD2 protein deficiency increased ROS levels by 108% in
young Apoe/ and by 75% in middle-aged Apoe/ mice in
cells within the media and atherosclerotic lesion cap. The
highest vascular ROS levels were present in the middle-aged
Apoe//Sod2+/ mice fed a Western diet, reflecting the
cumulative effect on the vessel wall from the interaction of
aging and hypercholesterolemia, the atherosclerotic risk
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Figure 1. Aortic atherosclerosis burden, aortic wall ROS levels and morphology in young and middle-aged Apoe//Sod2+/ compared with
Apoe/ mice. A, Representative images of oil red O–stained aortas and the atherosclerotic lesion area from 4- and 16-month-old mice fed a
Western diet for 3 months and atherosclerotic lesion area quantification (meanSEM, n=8). B and C, Representative images of mouse aorta
transverse sections stained with DHE (B) or MitoSOX red (C) and quantification of DHE and MitoSOX red fluorescence (meanSEM, n=8). D,
Representative images of aortic transverse sections stained for 8-OHdG (red) and DAPI (blue) and quantification of percentage of 8-OHdG-
positive nuclei (green) (meanSEM, n=9). E, Representative images of aortic transverse sections stained for 8-OHdG (red), ATP5G2 (green), and
smooth muscle a-actin (blue) and quantification of nonnuclear mitochondria-localized 8-OHdG-positive cells (meanSEM, n=7). High
magnification of insets (white rectangle) to the right show nuclear (red arrowheads) and mitochondrial (marked in dashed line and by yellow
arrowheads) localized 8-OHdG staining. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. DHE indicates dihydroethidium; mo, months; ROS,
reactive oxygen species; SEM, standard error of the mean.
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factors, with weakened antioxidant response due to
decreased SOD2 expression.
Because mtOS is associated with atherogenesis in both
humans and mouse models and mitochondrial antioxidant
enzymes regulate mitochondrial oxidative status,9,10,20 we
measured aortic mtROS levels, using MitoSOX fluorescence,
in the aortic walls of young and middle-aged Apoe/ and
Apoe//Sod2+/ mice on Western diet. Endogenous mtROS
levels were increased in atherosclerotic lesion cap area of
middle-aged Apoe/ (56% increase versus young Apoe/),
whereas SOD2 deficiency increased mtROS levels in young
Apoe//Sod2+/ (59% increase versus young Apoe/) to
the levels similar to middle-aged Apoe/ mice (Figure 1C).
Smaller but significant increases in mtROS levels were also
observed in middle-aged Apoe//Sod2+/ compared to
middle-aged Apoe/ (25%) and young Apoe//Sod2+/
(22%) mice. As in total vascular ROS levels, mtROS levels were
maximum in middle-aged Apoe//Sod2+/ compared to
other groups, indicating how cellular ROS in general and
mtROS in particular contribute to increased atherosclerotic
burden in middle-aged Apoe//Sod2+/ mice.
Increased DNA damage was reported in human
atherosclerotic plaque VSMC, promoting plaque instability.21
To understand the role of increased oxidative stress on
atherosclerotic plaque morphology in aging and hypercholes-
terolemia, we measured nuclear DNA damage by immunos-
taining aortic cross sections for 8-hydroxy-20-deoxyguanosine
(8-OHdG), an oxidative DNA damage marker.9 A significant
increase in 8-OHdG-positive nuclei was observed with age in
the aortas of both Apoe/ and Apoe//Sod2+/ mice
(P<0.05 versus respective young mice; Figure 1D), whereas
that number was higher in the aortas of both young and
middle-aged Apoe//Sod2+/ compared to age-matched
Apoe/ mice (P<0.001 and P<0.05, respectively). Two-way
ANOVA showed a significant interaction between the effects
of aging and genotype (P=0.0096), indicating that increased
nuclear DNA damage with age and SOD2 deficiency
increases atherosclerotic plaque burden and induces features
of plaque instability.
Because increased mtDNA damage was correlated with the
plaque size in experimental and human atherosclerosis and
considered a causal factor in atherogenesis,11,22 we also
investigated mtDNA damage in young and middle-aged
Apoe//Sod2+/ mice. Similar to nuclear DNA damage,
mtDNA damage, as determined by colocalization of
immunoreactive nonnuclear 8-OHdG and ATP synthase 5
subunit C2 (ATP5G2), a mitochondrial marker, increased with
age in the aortas of both Apoe/ and Apoe//Sod2+/ and
in young and middle-aged Apoe//Sod2+/ compared to
age-matched Apoe/ mice (Figure 1E). MtDNA damage was
prominent in VSMC of advanced atherosclerotic plaques and
was primarily evident in the fibrous cap area at the plaque
shoulder regions. SOD2 deficiency did not affect lipid
metabolism (Figure S1), further affirming the direct roles the
role of mtOS and mtDNA damage in age-associated
atherosclerosis in hypercholesterolemic settings.
Atherosclerotic Lesions in Middle-Aged Apoe/
/Sod2+/ Mice Exhibit Features of Vulnerable
Plaque
To determine whether SOD2 deficiency had an effect on
features of atherosclerotic plaque stability in aging under
hypercholesterolemic conditions, transverse aortic sections
from young and middle-aged Apoe/ and Apoe//Sod2+/
mice were examined for features that affect plaque stability,
including increased plaque macrophage infiltration,23,24
increased T cell content,25 increased necrotic core and
decreased fibrous cap thickness,4,5 decreased plaque SMC
content,26 the presence of intraplaque hemorrhage,27 and
fibrous cap integrity. First, inflammatory cell infiltration into
plaques, as determined by CD11b immunostaining, increased
with age in Apoe/ mice (Figure 2A), as described by us
previously.9 Inflammatory cell infiltration was also significantly
enhanced in young Apoe//Sod2+/ compared to young
Apoe/ mice. In contrast, inflammatory cell infiltration into
the plaques of 16-month-old Apoe//Sod2+/ was not
statistically different from age-matched Apoe/ mice. How-
ever, middle-aged Apoe//Sod2+/ mice had increased
activation of inflammatory pathways as indicated by a marked
increase in expression of immunoreactive vascular cell
adhesion molecule-1 (VCAM1) in atheroma and medial SMC
compared with young and age-matched Apoe/ mice
(Figure 2B). Second, an increased presence of CD3+ T-cells
was evident in the atheromas of middle-aged Apoe//
Sod2+/ compared with Apoe/ mice (Figure 2C), similar to
vulnerable plaques in humans.25 Third, necrotic core size,
determined by measuring the acellular area, resulting from
macrophage apoptosis, in the atherosclerotic plaque cross
sections was significantly higher in young Apoe//Sod2+/
compared with age-matched Apoe/ mice (P<0.05), and
increased with age in both genotypes (P<0.001) but was
significantly higher in middle-aged Apoe//Sod2+/ com-
pared to middle-aged Apoe/ mice (P<0.05; Figure 2D).
Fourth, fibrous cap thickness at the plaque shoulder region,
the common site of fibrous cap disruption and plaque
rupture,3 was similar in aortas of young Apoe/ and
Apoe//Sod2+/ mice but increased significantly in mid-
dle-aged Apoe/ mice (P<0.001; Figure 2E). However, cap
thickness was drastically decreased in middle-aged Apoe//
Sod2+/ versus age-matched Apoe/ mice (P<0.01), indi-
cating higher activation of inflammatory pathways and
increased extracellular matrix degradation with SOD2 defi-
ciency. A smaller but significant decrease in cap thickness
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was observed in middle-aged Apoe//Sod2+/ when com-
pared to young Apoe//Sod2+/ mice. Fifth, the SMC
content of the plaque, determined by smooth muscle actin
immunostaining, was significantly higher in young SOD2-
deficient Apoe/ mice compared to young Apoe/ mice
(P<0.001; Figure 2F). Similarly, the SMC content increased
significantly with age in plaques of Apoe/ mice (P<0.001).
However, atherosclerotic plaques from middle-aged Apoe/
/Sod2+/ mice had a significant decrease in SMC content
compared to young Apoe//Sod2+/ and middle-aged
Apoe/ mice. For both the fibrous cap thickness and plaque
SMC content, 2-way ANOVA demonstrated a significant
interaction between the effects of aging and SOD2 deficiency
(P<0.0001), suggesting that the decrease in these plaque
morphological features is characteristic of middle-aged
Apoe//Sod2+/ mice. Sixth, the presence of red blood
cells within the plaque, an indicator of intraplaque hemor-
rhage, was evident only in middle-aged Apoe//Sod2+/
mice (Figure 2G). Finally, analysis of atherosclerotic plaque
morphology showed that only middle-aged Apoe//Sod2+/
mice showed interruption of fibrous cap at the plaque
shoulder region without signs of thrombus formation, consis-
tent with a plaque fissure28 (Figure 2H). Together, these data
demonstrate that impairment of SOD2 activity in advanced
atherosclerosis induces features of an unstable plaque
phenotype.
Apoe-/- Apoe-/-/Sod2+/-
4 
m
o
16
 m
o
Apoe-/- Apoe-/-/Sod2+/-
4 
m
o
16
 m
o
0
25
50
75
100
C
D
11
b 
po
si
tiv
e 
ar
ea
(%
 o
f l
es
io
n 
ar
ea
) ***
NS
NS*
0
25
50
75
Fi
br
ou
s 
ca
p 
th
ic
kn
es
s 
(μ
m
)
***
*
**NS
0
1 0
2 0
3 0
4 0
N
ec
ro
tic
 c
or
e
(%
 o
f l
es
io
n 
ar
ea
) *** ***
* *
0
10
20
30
40
SM
-a
ct
in
 p
os
tiv
e 
ar
ea
(%
 o
f l
es
io
n 
ar
ea
) ***
***
**
***
A B
F
E
Apoe-/- 4 mo
Apoe-/- 16 mo
Apoe-/-/Sod2+/- 4 mo
Apoe-/-/Sod2+/- 16 mo
Apoe-/- Apoe-/-/Sod2+/-
4 
m
o
16
 m
o
Apoe-/- Apoe-/-/Sod2+/-
4 
m
o
16
 m
o
G
TER119
α-actin
DAPI
L
M
A
L
M
A
0
20
40
60
80
100
In
tra
pa
lq
ue
 h
em
or
rh
ag
e
(%
 p
os
iti
ve
 p
la
qu
es
) ***
**
L
M
A
4 
m
o
16
 m
o
Apoe-/- Apoe-/-/Sod2+/-
VCAM1
α-actin
DAPI
0
10
20
30 **
*
V
C
A
M
1 
ex
pr
es
si
on
(in
tD
en
/R
O
I c
el
l x
10
3 )
D
4 
m
o
16
 m
o
Apoe-/- Apoe-/-/Sod2+/-
0
0.5
1.0
1.5
2.0
2.5 **
*
C
D
3γ
 e
xp
re
ss
io
n
(In
tD
en
/R
O
I c
el
l x
10
3 )
C
CD3γ
α-actin
DAPI
*
A
po
e-
/-
A
po
e-
/- /
S
od
2+
/-
H
L
M
A
Figure 2. Atherosclerotic plaque morphology in young and middle-aged Apoe/ and Apoe//Sod2+/ mice. A, Representative images of
aortic transverse sections were stained for immunoreactive CD11b and inflammatory cell infiltration determined by quantification of the CD11b-
positive staining area (meanSEM, n=8). B and C, Representative images of aortic transverse sections stained for immunoreactive VCAM1 (B) or
CD3c (C) (red), smooth muscle a-actin (green), and DAPI (blue) and quantification of VCAM1 (B) or CD3c (C) expression represented as
fluorescence integrated density (IntDen) per number of cells (meanSEM, n=8). D, Necrotic core size was determined by measuring the
acellular fraction of the total plaque area (meanSEM, n=9). E, Representative images of transverse aortic sections stained with Verhoeff
picrosirius red and quantification of the fibrous cap thickness measured at the atherosclerotic plaque shoulder region (meanSEM, n=8). F,
Representative images of transverse sections stained for smooth muscle a-actin. Atherosclerotic plaque smooth muscle content was quantified
by measuring the a-actin-positive staining area (meanSEM, n=8). G, Representative images of aortic sections stained for TER119 (green),
smooth muscle a-actin (red) and DAPI (blue) and quantification of number of transverse aortic sections positive for intraplaque hemorrhage
(meanSEM, n=9). H, Representative images of transverse aortic sections from middle-aged Apoe/ and Apoe//Sod2+/ mice stained with
Verhoeff picrosirius red showing interruption of fibrous cap (arrowhead). A indicates atheroma; L, lumen; M, media. Scale is 100 lm. *P<0.05;
**P<0.01; ***P<0.001; NS, not significant; SEM, standard error of the mean.
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Increase in mtROSWith Aging in VSMC of Sod2+/
Mice Induces Mitochondrial Dysfunction
To understand the mechanisms that regulate VSMC function
in the progression of advanced atherosclerotic lesions during
aging and to avoid the confounding effects of hypercholes-
terolemia, we examined mitochondrial function in VSMC
isolated from young and middle-aged wild-type and Sod2+/
mice. Because atherosclerotic plaque SMC are exposed to
IFNc secreted by T-cells and TNFa from activated macro-
phages in the lesions,29 we first determined the combined
effect of these 2 cytokines on VSMC ROS levels by measuring
2-hydroxyethidium, a superoxide-specific product of hydro-
ethidine, by HPLC analysis. The TNFa and IFNc-induced
superoxide levels were significantly higher in the cells from
both middle-aged wild-type and Sod2+/ mice compared to
their respective young controls (Figure 3A). In addition, SOD2
deficiency significantly enhanced cytokine-induced superox-
ide levels in VSMC from middle-aged wild-type mice. To
determine whether the cytokines exert an effect primarily on
mtROS levels, VSMC were treated with the cytokines in the
presence and absence of MitoTEMPO.9 MitoTEMPO pretreat-
ment decreased cellular ROS levels to near-basal levels in all
the groups, indicating that the observed increases in super-
oxide levels in response to various vasoactive agonists in
aortic VSMC were of mitochondrial origin. However, Mito-
TEMPO treatment did not decrease ROS to the basal levels of
young mice VSMC, suggesting that extramitochondrial
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Figure 3. Increased mtROS results in impaired mitochondrial function in VSMC from 4- vs 16-month-old
Sod2+/ mice. A, Superoxide generation was measured by 2-OH-ethidium HPLC analysis in VSMC treated
with 100 ng/mL TNFa, 200 ng/mL IFNc, and/or 10 lmol/L MitoTEMPO. Results were normalized to
protein concentration (meanSEM, n=4). B, Mitochondrial protein carbonyl content was determined in
mitochondria isolated from VSMC. Results were normalized to protein concentration (meanSEM, n=6). C
and D, Mitochondrial complex I (C) and complex III (D) activities in VSMC presented as changes in
substrate concentration adjusted to protein concentration (meanSEM, n=4). *P<0.05; **P<0.01;
***P<0.001; ****P<0.0001. HPLC indicates high-precision liquid chromatography; mo, months; mtROS,
mitochondrial reactive oxygen species; SEM, standard error of the mean; VSMC, vascular smooth muscle
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sources of cellular superoxide such as NADPH oxidases,
lipoxygenases, and monoamine oxidase may contribute to
aging-associated oxidative stress.
The current data showing a significant increase in
carbonylation of mitochondrial proteins with age in VSMC
from Sod2+/ mice compared to wild-type (Figure 3B) are
consistent with our prior results, which showed the associ-
ation of increased mtROS levels with mitochondrial protein
oxidative modification during aging.9 Reflecting the increased
protein carbonylation, activities of mitochondrial complex I
and complex III were significantly lower in VSMC from both
middle-aged wild-type and Sod2+/ mice compared with their
respective young controls; the SOD2 deficiency had an even
greater inhibitory effect on age-associated decline in complex
I and III activities in VSMC (P<0.05 versus wild-type;
Figure 3C and 3D). Together, these data showed that the
impaired antioxidant defense system further exacerbates the
adverse effects of aging on mitochondrial oxidative burden
and function in the aortic vascular cells.
Aging-Associated Mitochondrial Dysfunction
Induces Activation of Calpain-2 and MMP2 and
DNA Damage in VSMC From Sod2+/ Mice
Calpains are calcium-sensitive cysteine proteases that regu-
late inflammation, induce apoptosis, activate MMP2, and
facilitate fibrotic changes in aortic wall in aging and
atherosclerosis.30,31 To determine whether SOD2 deficiency
and inflammatory cytokines affect calpain expression during
aging, we measured calpain-1 and calpain-2 expression in
VSMC from young and middle-aged wild-type and Sod2+/
mice at basal levels and in response to TNFa+IFNc treatment.
Calpain-1 expression was 3.5-fold higher in VSMC from both
middle-aged wild-type and Sod2+/ mice compared with their
respective controls (Figure 4A). However, TNFa+IFNc treat-
ment had no significant effect on calpain-1 expression in
VSMC from both young and middle-aged mice. Basal calpain-2
expression was higher in VSMC from young Sod2+/ mice
versus wild-type mice. Its expression increased with age in
cells from both groups but was significantly higher in the
VSMC from middle-aged Sod2+/ than in cells from middle-
aged wild-type mice (Figure 4A). TNFa+IFNc treatment
caused a robust increase of calpain-2 protein levels in VSMC
from middle-aged versus young Sod2+/ mice but had no
effect in cells from either young or middle-aged wild-type
mice, suggesting that increased mitochondrial oxidative
stress in aging selectively upregulates vascular calpain-2
expression (Figure 4A). To determine whether increased
calpain-2 expression regulates VSMC apoptosis, we trans-
fected VSMC with nontargeting siRNA:p5RHH or Capn2
siRNA:p5RHH nanocomplexes14 and measured cleaved cas-
pase-3 expression by Western analysis. Capn2 siRNA
transfection selectively and significantly decreased basal
calpain-2 protein levels in VSMC from middle-aged wild-type
mice (Figure S2) and TNFa+IFNc–induced calpain-2 levels in
VSMC from both young and middle-aged wild-type and Sod2+/
 mice compared to nontargeting siRNA (Figure 4B). Cleaved
caspase-3 protein levels, which increased with age in both the
cell types but significantly in VSMC from Sod2+/ mice, were
attenuated with Capn2 siRNA transfection (Figure 4B). In
contrast, Capn2 siRNA transfection had no effect on
TNFa+IFNc–induced cleaved caspase-3 levels in wild-type
cells. Together, these data show that impaired antioxidant
defense in aging activates signaling pathways that affect
VSMC viability in the vascular wall.
Basal MMP2 protein levels were significantly higher in both
young and middle-aged Sod2+/ VSMC compared to the wild-
type cells; aging further increasing the protein levels in
Sod2+/ cells (Figure 4C). TNFa+IFNc treatment had no
significant effect on MMP2 protein content in young and
middle-aged wild-type and young Sod2+/ VSMC. However,
the MMP2 protein content was increased 2.6-fold in middle-
aged Sod2+/ VSMC treated with TNFa+IFNc. Pretreatment
of cells with calpain inhibitor PD150606 significantly
decreased basal as well as TNFa+IFNc–induced MMP2 levels
in both wild-type and Sod2+/ VSMC (Figure 4C), suggesting
that calpains are major regulators of MMP2 expression in
VSMC.31,32 Because calpains regulate apoptosis30 and DNA
damage induces VSMC apoptosis,33 we asked whether
calpain induction regulates DNA damage in VSMC in aging
under increased mtOS. Phosphorylation of histone H2AX
(cH2AX), a marker of DNA double-strand breaks and DNA
damage response,21 was significantly increased with age in
both wild-type and Sod2+/ VSMC (Figure 4C). The
TNFa+IFNc treatment had no effect on cH2AX levels in both
young and middle-aged wild-type and young Sod2+/ VSMC
but caused a significant increase (2.5-fold) in middle-aged
Sod2+/ VSMC. Pretreatment with PD150606 decreased
cH2AX to near basal levels in middle-aged Sod2+/ VSMC,
providing evidence for the regulatory role of calpains in DNA
damage in VSMC with increased mtOS during aging. Taken
together, these data indicate that impaired SOD2 activity in
aging might affect features of plaque stability by inducing
mitochondrial dysfunction, matrix degradation, and VSMC
apoptosis via increased mitochondrial protein oxidation and
regulation of calpains, particularly calpain-2.
Atherosclerotic Plaque Shoulder Regions in
Middle-Aged Apoe//Sod2+/ Mice Show
Increased Calpain-2 and MMP2 Expression and
Matrix Remodeling
It was previously reported that calpain-2 levels were signif-
icantly elevated in low-density lipoprotein receptor knockout
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(Ldlr/) mice fed a high-cholesterol diet, and calpain
inhibitors suppressed hypercholesterolemia-induced
atherosclerosis and vascular inflammation.34 Further,
increased calpain and caspase-3 activities in isolated perfused
hearts were significantly reduced in transgenic mice with
cardiac-specific overexpression of SOD2 compared with
hearts of wild-type mice.35 To determine whether SOD2
deficiency affects features of atherosclerotic plaque stability
in aging under hypercholesterolemic conditions by regulating
calpain levels, we performed immunofluorescence analysis of
calpain-2 levels in atherosclerotic plaque shoulder regions of
young and middle-aged Apoe/ and Apoe//Sod2+/ mice
fed a Western diet. SOD2 deficiency markedly increased
immunoreactive calpain-2 expression in plaque shoulder
regions in the young and significantly in the middle-aged
Apoe/ mice (P<0.01 versus Apoe/ 16 months and
Apoe//Sod2+/ 4 months; Figure 5A, top and middle
panels). Specifically, calpain-2 expression was significantly
increased in the plaque SMC constituting the fibrous cap
(Figure 5A, middle panel). Compared with Apoe/, some
middle-aged Apoe//Sod2+/ mice had depleted intimal
SMC content in the atherosclerotic lesions and the absence of
immunoreactive calpain-2 at the plaque shoulder regions but
not in media (Figure 5A, lower panel). A significant increase in
expression of immunoreactive cleaved caspase-3 was con-
fined to intimal SMC in middle-aged Apoe//Sod2+/ aortas
(P<0.05 versus Apoe/ 16 months and Apoe//Sod2+/
4 months), whereas it was minimal and restricted to the
necrotic core area in middle-aged Apoe/ aortas (Figure 5B,
top and middle panels). The plaque shoulder regions with
depleted intimal SMC content had low levels of immunore-
active cleaved caspase-3 (Figure 5B, lower panel), suggesting
that intimal SMC apoptosis is induced by calpain-2-mediated
activation of caspase-3.36
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Because calpains activate matrix-degrading metallopro-
teinases31 and MMP2 activity increases in the arterial wall of
middle-aged Sod2+/ mice,13 we analyzed MMP2 expression
in mouse atherosclerotic plaque shoulder regions. The
immunoreactive MMP2 expression was markedly increased
in the fibrous cap as well as in total atherosclerotic plaque
area in Apoe//Sod2+/ compared with Apoe/ mice;
MMP2 expression was significantly higher in middle-aged
Apoe//Sod2+/ than in other mouse groups (Figure 5C).
Analysis of aortic sections stained with picrosirius red in
polarized light showed evenly distributed collagen fibers in
fibrous caps in 4-month-old Apoe/ and Apoe//Sod2+/
mice. The collagen fibers were compactly arranged in
atherosclerotic lesions of 16-month-old Apoe/, whereas
they were disorganized in middle-aged Apoe//Sod2+/
mice (Figure 5D). In addition, the amount of fibrous cap
collagen was significantly lower in atherosclerotic plaque
fibrous cap of middle-aged Apoe//Sod2+/ mice. These
results suggest that increased mtOS in aging under
hypercholesterolemic conditions promotes features of
atherosclerotic plaque vulnerability by inducing calpain-2
expression, increasing caspase-3 activation and MMP2-
mediated SMC apoptosis and matrix degradation in the
plaque shoulder regions, resulting in thin fibrous caps with
low cellularity.
Phenotypic transition of atherosclerotic plaque VSMC into
macrophage-like cells enhances intraplaque inflammation and
contributes to the plaque pathogenesis.37 To assess whether
aging and SOD2 deficiency contribute to SMC transdifferen-
tiation, we analyzed mouse atherosclerotic plaques for cells
coexpressing markers of both SMC (SMMHC and a-actin) and
macrophage (CD68 and Mac3) lineages.38,39 Cells costained
with immunoreactive SMMHC and CD68 were primarily
localized to the core area of the plaque. The proportion of
these cells to all CD68+ cells increased significantly in the
plaque core of middle-aged Apoe/ and Apoe//Sod2+/
as compared to young mice but was not significantly different
between the genotypes (Figure S3). Similarly, the number of
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cells costained with immunoreactive Mac3 and a-actin
increased significantly in atherosclerotic plaques of middle-
aged compared with young mice. These data suggest that
aging may enhance plaque SMC transdifferentiation resulting
in increased accumulation of inflammatory cells in the core. A
lack of significant difference between aged Apoe/ and
Apoe//Sod2+/ mice suggests that mtOS contributes to
the core expansion through increased cell apoptosis rather
than SMC transdifferentiation.
MitoTEMPO Reduces Features of Plaque
Vulnerability in Middle-Aged Apoe//Sod2+/
Mice
Because MitoTEMPO treatment attenuated the aging-asso-
ciated increase in atherosclerosis,9 we examined whether it
would exert similar salutary effects on plaque morphology in
advanced atherosclerosis by treating middle-aged Apoe/
and Apoe//Sod2+/ mice fed a Western diet with
MitoTEMPO or vehicle for 3 months. A significant reduction
in atherosclerotic burden in MitoTEMPO versus vehicle-treated
Apoe/ mice (Figure 6A) is consistent with our previous
data.9 However, MitoTEMPO had no significant inhibitory effect
on plaque burden in middle-aged Apoe//Sod2+/mice with
advanced atherosclerosis, although the lesion size trended
downward with the treatment. It would be worth investigating
whether a higher dose or longer treatment of MitoTEMPO
significantly reduces atherosclerotic burden in these mice.
Nevertheless, MitoTEMPO treatment of middle-aged Apoe/
and Apoe//Sod2+/ mice significantly decreased plasma
free 8-isoprostane levels, a measure of systemic oxidative
stress (Figure 6B). Neither MitoTEMPO nor vehicle had
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Figure 6. MitoTEMPO treatment reduced mtOS and atherosclerotic plaque remodeling but not atherosclerosis progression in middle-aged
Apoe//Sod2+/ mice. A, Representative images of oil red O–stained aortas and quantification of atherosclerotic lesions in 16-months old
Apoe/ and Apoe//Sod2+/ mice treated with MitoTEMPO and fed a Western diet for 3 months (meanSEM, n=8). B, Plasma levels of free
8-isoprostane (meanSEM, n=8). C, Representative images and quantification of mouse aorta transverse sections stained with MitoSOX Red
(meanSEM, n=7). D, Representative images of aortic transverse sections stained for 8-OHdG (red), ATP5G2 (green), and DAPI (blue), and
quantification of mitochondrial 8-OHdG-positive cells (meanSEM, n=5). E, Atherosclerotic lesion necrotic core size presented as acellular
fraction of the total plaque area (meanSEM, n=7). F, Representative images of aortic transverse sections stained with Verhoeff picrosirius red
and quantification of the fibrous cap thickness at the atherosclerotic plaque shoulder region (meanSEM, n=7). G, Representative fluorescent
microscopy images of aortic sections stained for TER119 (green), smooth muscle a-actin (red), and DAPI (blue) and quantification of the number
of aortic sections showing intraplaque hemorrhage (n=7). A indicates atheroma; L, lumen; M, media; mo, months; mtOS, mitochondrial oxygen
stress; NS, not significant; SEM, standard error of the mean. Scale is 100 lm. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.
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significant effects on lipid metabolism in middle-aged mice
(Figure S4A and S4B). The treatment protocol had no toxic
effects as determined by blood urea nitrogen (Figure S4C),
creatinine (Figure S4D), alanine aminotransferase (Figure S4E)
levels and kidney (Figure S4F) or liver morphological changes
(Figure S4G). Atherosclerotic plaque mtROS levels were
significantly decreased by MitoTEMPO in both middle-aged
Apoe/ and Apoe//Sod2+/ mice (Figure 6C). Addition-
ally, MitoTEMPO significantly lowered the number of cells with
8-OHdG modification of mtDNA at the atherosclerotic plaque
shoulder regions in both genotypes (Figure 6D).
Analysis of aortic cross sections showed that necrotic core
size, which was significantly increased in middle-aged Apoe/
/Sod2+/ versus middle-aged Apoe/ mice, was markedly
decreased in response to MitoTEMPO treatment (Figure 6E).
Additionally, Verhoeff picrosirius red staining of aortic
sections showed that the fibrous cap thickness at the
shoulder regions of atherosclerotic plaque, which was
markedly decreased in vehicle-treated middle-aged Apoe/
/Sod2+/ versus middle-aged Apoe/ mice, was signifi-
cantly increased after MitoTEMPO treatment (Figure 6F). In
addition, treatment with MitoTEMPO resulted in a marked
reduction in the presence of red blood cells within the plaque
in middle-aged Apoe//Sod2+/ mice (Figure 6G). These
results showed that MitoTEMPO treatment in middle-aged
mice markedly reduced features of vulnerable plaque.
Further analysis of atherosclerotic plaques in mice treated
with MitoTEMPO revealed a substantial reduction in
immunoreactive calpain-2 expression in middle-aged Apoe/
/Sod2+/ versus vehicle-treated mice (Figure 7A). Corre-
spondingly, the fibrous cap at the shoulder regions of
atherosclerotic plaque demonstrated higher cellularity and
SMC content in MitoTEMPO-treated versus vehicle-treated
middle-aged Apoe//Sod2+/ mice. Similarly, the
immunoreactive cleaved caspase-3 expression was reduced
and fibrous cap SMC content was preserved by MitoTEMPO
treatment in atherosclerotic plaque of middle-aged Apoe//
Sod2+/ mice (Figure 7B). Further, TUNEL-stained aortic
sections showed a significant increase in the number of
TUNEL+ medial and intimal SMC as well as core macrophages
in middle-aged Apoe//Sod2+/ versus Apoe/ mice
(Figure 7C); MitoTEMPO treatment markedly decreased the
percentage of TUNEL+ cells in the middle-aged Apoe//
Sod2+/ mice. In addition, MitoTEMPO treatment significantly
reduced MMP2 expression by medial and neointimal SMC (a-
actin+; Figure 7D) as well as plaque macrophages (CD68+
cells; Figure S5) in the atherosclerotic lesions of middle-aged
Apoe//Sod2+/ mice. Consistent with increased expres-
sion levels, in situ zymography using fluorescein-labeled MMP
substrate showed increased MMP2 activity (enhanced cleaved
substrate accumulation) in the atherosclerotic aortas from
middle-aged Apoe//Sod2+/ compared with middle-aged
Apoe/ mice; MMP2 activity was noticeably reduced in
MitoTEMPO-treated aortas from middle-aged Apoe//
Sod2+/ mice (Figure 7E). As a consequence of reduced
MMP2 expression and activity, analysis of polarized micro-
scopy images of aortic sections stained with picrosirius red
showed the enhanced presence of organized collagen fibers in
the shoulder region of atherosclerotic plaques from Mito-
TEMPO-treated Apoe//Sod2+/ mice (Figure 7F). Taken
together, these data suggest that even in the absence of a
significant reduction in atherosclerotic lesion size, Mito-
TEMPO treatment may exert a salutary effect on advanced
atherosclerosis in aging under hypercholesterolemic condi-
tions by inhibiting mtOS, reducing apoptosis, and attenuating
features of atherosclerotic plaque vulnerability.
Discussion
The present studies were designed to determine the interplay
of impaired SOD2 activity, aging, and hypercholesterolemia on
aortic atherosclerotic burden and on features of atheroscle-
rotic plaque stability, which are associated with major adverse
cardiovascular events.40 We used middle-aged, 16-month-old
mice, which are equivalent to 54-year-old humans,41,42 an
age group with an exponential increase in the incidence of
coronary heart disease and other cardiovascular diseases
compared to a younger 20- to 39-year age group.2 Lifelong
deficiency of SOD2 activity increased atherosclerotic lesion
volume and multiple features of plaque vulnerability in middle-
aged hyperlipidemic mice, including decreased plaque SMC
content and fibrous cap thickness, increased VCAM1 expres-
sion and T-cell content, enlarged necrotic core size, and
evidence of intraplaque hemorrhage and plaque fissures. The
fibrous cap changes compatible with plaque fissure observed
in these mice may also be a source of intraplaque hemor-
rhage.43 In addition, our data provide evidence that in SOD2-
deficient mice, mtOS regulates calpain-2 expression in
advanced atherosclerosis, and caplain-2 may mediate fea-
tures of plaque vulnerability, including decreased plaque SMC
content and fibrous cap thickness, via the activation of
caspase-3 and MMP2, respectively. It is also possible, but less
likely, that calpain-1-dependent MMP2 expression contributes
to plaque instability in middle-aged Apoe//Sod2+/ mice
fed a Western diet as a significant, albeit similar, increase in
calpain-1 expression was observed in VSMC from aged wild-
type and middle-aged Sod2+/ mice. More importantly, these
studies show that although MitoTEMPO treatment did not
significantly reduce aortic atherosclerotic burden, it did
preserve features of plaque stability including SMC content
and fibrous cap thickness in middle-aged hyperlipidemic
Sod2+/ mice; the most salutary effects were seen in
inhibiting SMC apoptosis, macrophage recruitment, and
inhibition of calpain-2 expression and caspase-3 and MMP2
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activities. Taken together, these data suggest that increased
mtOS and mitochondrial dysfunction under hyperlipidemic
conditions in aging not only increases atherosclerotic plaque
volume but also induces features of plaque instability, by
accentuating DNA damage, perhaps via calpain-2-mediated
mechanisms.
The current data showing extensive and advanced
atherosclerosis in middle-aged hyperlipidemic SOD2+/ mice
are consistent with a previous report in which age-accelerated
atherosclerosis in lipoprotein receptor knockout mice was
attributed to an inability to mount a robust antioxidant
response.12 In this context, it is worth noting that the
increased oxidized low-density lipoprotein levels under hyper-
lipidemic conditions, as seen in Apoe/ mice, exacerbate
mtROS production and induce cell apoptosis by stimulating
SOD2 ubiquitination and degradation.44 We and others
demonstrated previously that cellular ROS levels are corre-
lated with mtDNA damage, an early event in
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Figure 7. Treatment with MitoTEMPO decreases smooth muscle apoptosis and matrix remodeling and preserves fibrous cap integrity in the
atherosclerotic plaque shoulder region in middle-aged Apoe//Sod2+/ mice. A and B, Representative fluorescent microscopy images and
quantification of aortic sections stained for immunoreactive calpain-2 (A), cleaved caspase-3 (B) (red), smooth muscle a-actin (green) and DAPI
(blue). Data presented as fluorescence integrated density (IntDen) per number of cells (meanSEM, n=5). C, Representative fluorescent
microscopy images of TUNEL-stained aortic sections (TUNEL—red, nuclei—blue, TUNEL+ nuclei—pseudo-colored green) and quantification of
TUNEL+ nuclei (meanSEM, n=5). D, Representative fluorescent microscopy images of aortic sections stained for MMP 2 (red), smooth muscle
a-actin (green) and DAPI (blue). Data presented as fluorescence integrated density (IntDen) per number of cells (meanSEM, n=5). E,
Representative fluorescent microscopy images of aortic sections following in situ zymography (green) and stained with DAPI (blue) and
quantification of cleaved substrate fluorescence per number of cells in atherosclerotic plaque section (meanSEM, n=5). F, Representative
polarized microscopy images of aortic sections stained with picrosirius red (A indicates adventitia; L, lumen; n=5). Scale is 100 lm. *P<0.05;
**P<0.01; ***P<0.001; ****P<0.0001. IntDen indicates integrated density; MMP, matrix metalloproteinase; ROI, region of interest; SEM,
standard error of the mean; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
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atherogenesis.11,45 The results of the present studies demon-
strating increased features of atherosclerotic plaque vulner-
ability with increases in mtOS and mtDNA damage are
consistent with a report by Yu et al22 that mtDNA damage is
an indicator of high-risk plaques in advanced atherosclerosis.
Our results demonstrate that plaque SMC content
increased in both young Apoe/ mice that were deficient
in SOD2 as well as in middle-aged Apoe/ mice with
increased endogenous mtROS levels. In contrast, the plaque
SMC content decreased significantly in middle-aged Apoe/
/Sod2+/ mice, indicating “threshold effects” of decreased
SOD2 activity on atherosclerosis in aging and under hyper-
lipidemic conditions; lower levels of mtROS increase
atherosclerotic plaque burden by promoting SMC prolifera-
tion, but when SOD2 activity falls below a minimum threshold
required for cell survival, plaque instability results.46 It is
relevant that SMC apoptosis is sufficient for the progression
of the plaque to an unstable state.47 Increased VCAM1 levels
in atheroma and medial SMC in middle-aged Apoe//
Sod2+/ mice suggest that impaired SOD2 activity increases
and sustains endothelial, SMC, and macrophage-derived
inflammation, which could lead to evolution of the inflamed
lesion into an unstable plaque.48 Increased infiltration of CD3+
T cells in advanced atherosclerotic lesions in middle-aged
Apoe//Sod2+/ mice on activation by LDL fragments could
destabilize plaques by secreting TNFa and IFNc.5 The
macrophage-activating interferon promotes a vulnerable phe-
notype by inducing inflammation of both endothelial cells and
SMC and inhibiting collagen synthesis by SMC, affecting
fibrous cap thickness, as observed in the present study.
Recent evidence indicates that SMC within lesions transi-
tion to cells with multiple phenotypes including macrophage-
like cells with increased expression of proinflammatory
cytokines, affecting plaque composition and stability.37 Our
results suggest that these processes are enhanced during
aging and, in conjunction with increased mtOS, promote
apoptosis and expansion of the necrotic core. The infiltration
of erythrocytes in the lesions in middle-aged Apoe//Sod2+/
 mice on a high-fat diet is an indication of hemorrhage and
evidence of intraplaque microvessels, which increase lesion
vulnerability by facilitating continued extravasation of inflam-
matory cells into the lesions.49 Increased blood pressure,
another significant factor influencing plaque stability,
increases peak circumferential stress at the plaque shoul-
der.50 The elevated diastolic blood pressure and increased
arterial stiffness in aged Sod2+/ mice13 might increase peak
circumferential stress and, in combination with decreased cap
thickness, may trigger plaque rapture at the shoulder region.51
The data from our mechanistic studies on mouse aortic
SMC, which are consistent with the in vivo findings, elucidate
the underlying molecular mechanisms affecting atherosclerotic
plaque burden and plaque vulnerability when multiple
atherosclerotic risk factors including aging, increased oxidative
stress, and hyperlipidemia converge on the vessel wall. Our
results showing increased nuclear DNA damage in the aortas of
middle-aged Apoe//Sod2+/ mice are consistent with a
previous report that demonstrated elevated levels of 8-OHdG in
nuclear DNA in SOD2+/ mice.52 This is important because
nuclear DNA damage promotes mitochondrial dysfunction and
mtDNA damage,53 which increases atherogenesis and induces
plaque vulnerability, as observed by a significant decline in the
activities of mitochondrial complexes I and III in VSMC from
middle-aged SOD2+/ mice exposed to the inflammatory
cytokines TNFa and IFNc as well as increased mitochondrial 8-
OHdG levels in the plaques of middle-aged Apoe//Sod2+/
mice. Decreased mitochondrial ATP generation from mtDNA
damage and mitochondrial dysfunction dysregulates cellular
Ca2+ homeostasis by impairing the activity of the plasma
membrane and sarcoplasmic reticulum Ca2+-ATPase.54 The
opening of mitochondrial permeability transition pores follow-
ing mitochondrial dysfunction55 from prolonged mtOS in
middle-aged Apoe//Sod2+/ mice on high-fat diets may
also contribute to increased cytosolic Ca2+ levels, activating
calpains. Here, it is of particular interest to note that Ca2+-
dependent calpain activation, cytochrome C release, and
caspase-3 activation were reported in human microvascular
endothelial cells exposed to oxidized LDL.56 Calpains have
been implicated in atherosclerosis30,34; however, our data
reveal for the first time that SOD2 is an important regulator of
calpain-2 induction, which mediates plaque vulnerability in
mice during aging under hyperlipidemic conditions. In contrast
to the report of Miyazaki et al34 that calpain-2 is preferentially
induced in endothelial cells in atheroma, our data show robust
expression of the protease in SMC, both in vitro and in
atherosclerotic lesions. Selective activation of caspase-3 by
calpain-2 but not calpain-1 was previously reported,36 which
supports our results of selective activation of caspase-3 in a
calpain-2-dependent manner. Additionally, our results showing
that calpain-2 regulates MMP2 expression are consistent with
a previous study showing that MMP2 expression in aging is
regulated by calpains.31 The increased expression of MMP2
along with depleted and disorganized collagen fibers in
atherosclerotic plaque shoulder regions of middle-aged
Apoe//Sod2+/ mice (indicating increased plaque vulner-
ability) are consistent with the data from the Atherosclerosis
Risk in Communities Carotid MRI Study in which the MMP2
C1306T variant is associated with lower MMP2 expression and
a thicker fibrous cap.57
The morphological features of advanced atherosclerotic
plaques in middle-aged mice that we describe are relevant to
age-dependent changes in human atherosclerosis. Kang et al
reported that patients who are smokers and >65 years had
more plaque burden and plaque instability (more necrotic
core, thin-cap fibroatheromas, and positive remodeling) and
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more ruptures compared to patients who are nonsmokers and
≤65 years.58,59 In a similar report, Wendorff et al found a
continuous increase in carotid plaque instability in men with
age and a significant increase in plaque instability in the 65-
to 69-year-old age group of patients in the probability analysis
of age-associated quartiles related to the first quartile.60
Statins have been established as the best pharmacother-
apy for reduction of cardiovascular risk. In addition to
lowering lipid levels, statins exert plaque stabilization effects
by reducing intraplaque hemorrhage, plaque neovasculariza-
tion, and endothelial dysfunction.26,49 However, a significant
residual cardiovascular risk remains in patients on statin
treatment. The success of immunomodulatory agents such as
blocking antibodies against IFNc and CCL5 antagonists in
inducing plaque stabilization in mouse models highlights the
importance of inflammation in plaque destabilization. These
reports are entirely consistent with the results of the present
investigation showing that MitoTEMPO treatment improves
atherosclerotic plaque stability in aging-associated
atherosclerosis by attenuating mtOS and vascular inflamma-
tion. Also of potential relevance for cardiovascular risk
reduction are reports that MitoTEMPO exerts salutary effects
on angiotensin II–induced hypertension61 and aging-asso-
ciated decline in arterial compliance9 in mouse models. More
importantly, MitoTEMPO reduced hypertension and improved
vasorelaxation in a mouse model of hyperacetylated and
hypofunctional SOD2.62 Targeting mtOS and dysfunction
using mitochondria-targeted antioxidants, such as Mito-
TEMPO, in combination with statins may represent an
important opportunity for prevention of atherosclerotic plaque
progression and instability during aging.
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Supplemental Figure Legends 
Figure S1. Plasma lipids levels in young and aged Apoe-/- compared with Apoe-/-/Sod2+/- mice. 
A-B, Plasma levels of total cholesterol (A) and triglycerides (B). Data are mean ± SEM, n=12. 
Figure S2. Transfection of VSMC from middle-age wild-type mice with Capn2 siRNA:p5RHH 
nanocomplexes effectively reduces calpan-2 but not calpain-1 expression levels. Western blot 
analysis of calpain-2 and calpain-1 expression in VSMC transfected with scrambled siRNA or 
Capn2 siRNA:p5RHH nanocomplexes. 
Figure S3. Features of plaque VSMC transdifferentiation to macrophage-like cells in Apoe-/- and 
Apoe-/-/Sod2+/- mice. (A) Representative fluorescent microscopy images of fresh frozen 
transverse aortic sections stained for immunoreacative CD68 (red), smooth muscle SM-MHC 
(green), and DAPI (blue) and quantification of proportion of CD68+ SM-MHC+ cells relative to 
total core CD68+ cells (mean ± SEM, n=6). (B) Representative fluorescent microscopy images 
of fresh frozen transverse aortic sections stained for immunoreacative Mac3 (green), smooth 
muscle α-actin (red), and DAPI (blue) and quantification of proportion of Mac3+ α-actin+ cells 
relative to total plaque Mac3+ cells (mean ± SEM, n=6). *P<0.05. Scale is 100 µm. 
Figure S4. Systemic effects of MitoTEMPO treatment in middle-aged Apoe-/- and Apoe-/-/Sod2+/- 
mice. A-E, Plasma levels of total cholesterol (A), triglycerides (B), blood urea nitrogen (BUN) 
(C), creatinine (D), and alanine aminotransferase (E). Data are mean ± SEM, n=8. F-G, 
Representative images of mouse kidney (F) and liver (G) sections stained with H&E. N=4. Scale 
is 100 μm. 
Figure S5. MMP2 expression in CD68+ macrophages in atherosclerotic lesions of middle-aged 
mice treated with MitoTEMPO. Representative fluorescent microscopy images of fresh frozen 
transverse aortic sections stained for immunoreacative MMP2 (green), CD68 (red) and DAPI 
(blue) and quantification of MMP2 expression in CD68+ cells represented as fluorescence 
integrated density (IntDen) per number of cells (mean ± SEM, n=6). Scale is 100 μm. *P<0.05; 
**P<0.01. 
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